PCI Biotech Holding ASA (FRA:4QG) Other Current Liabilities : €0.42 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA Other Current Liabilities?

PCI Biotech Holding ASA's other current liabilities for the quarter that ended in Dec. 2024 was €0.42 Mil.

PCI Biotech Holding ASA's quarterly other current liabilities increased from Dec. 2023 (€0.27 Mil) to Jun. 2024 (€0.31 Mil) and increased from Jun. 2024 (€0.31 Mil) to Dec. 2024 (€0.42 Mil).

PCI Biotech Holding ASA's annual other current liabilities declined from Dec. 2022 (€0.34 Mil) to Dec. 2023 (€0.27 Mil) but then increased from Dec. 2023 (€0.27 Mil) to Dec. 2024 (€0.42 Mil).

PCI Biotech Holding ASA Other Current Liabilities Historical Data

The historical data trend for PCI Biotech Holding ASA's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Other Current Liabilities Chart

PCI Biotech Holding ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

1.12

1.46

0.34

0.27

0.42

PCI Biotech Holding ASA Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Current Liabilities	Get a 7-Day Free Trial															0.34	0.22	0.27	0.31	0.42

PCI Biotech Holding ASA Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

PCI Biotech Holding ASA Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PCI Biotech Holding ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (FRA:4QG) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

PCIB:Norway 0JGL:UK

Address

Ullernchausseen 64, Oslo, NOR, N-0379

Website

https://www.pcibiotech.com

PCI Biotech Holding ASA is a biopharmaceutical company focused on developing and commercializing cancer therapies using its photochemical internalization (PCI) technology platform. The PCI technology utilizes light to trigger the release of compounds from within cellular compartments. The company applies PCI to three different approaches for cancer treatment: fimaCHEM: Enhancing chemotherapeutic drugs for localized cancer treatment. fimaVACC: Inducing T-cell responses for therapeutic cancer vaccination. fimaNAc: Delivering nucleic acid therapeutics. The key product candidate is fimaporfin (Amphinex), a photosensitizer that can unlock intracellular compartments where active compounds are trapped. The company's sole operating segment is research and development.

PCI Biotech Holding ASA Headlines

No Headlines